The US Advisory Committee on Immunization Practices voted in June to stop recommending certain kinds of flu vaccines, a ...

The multicomponent mRNA-1083 vaccine elicited noninferior immune responses in adult patients when compared with coadministered influenza and COVID-19 vaccines.

Seasonal flu-related hospitalizations and outpatient visits reached a 15-year high during the 2024-25 season, according to the Centers for Disease Control and Prevention.

Moderna’s experimental mRNA-based flu vaccine demonstrated a stronger immune response than a currently available standard flu shot in a late-stage phase 3 trial, clearing a path for regulatory ...

Moderna said on Monday its experimental influenza vaccine was found to be 26.6% more effective than a currently approved ...

Kennedy’s decision to replace ACIP wholesale and the comments he has made about deviating from standard vaccine policymaking ...

Of the study population, 82% had received the seasonal flu vaccine – a typical percentage for healthcare settings where vaccination is often strongly encouraged or required. The results have ...

"The influenza vaccine can be highly effective in reducing the severity of illness, preventing hospitalizations, and minimizing the spread of the virus, but its effectiveness can vary depending on ...

The 2024-2025 COVID-19 and influenza vaccines provided protection against ED/UC, outpatient visits, and hospitalizations. In the 2024-2025 season, the COVID-19 vaccine provided additional ...

This year’s flu vaccine has been effective overall against the current strains of the virus, despite cases and hospitalizations surging in the region, according to the latest federal data. About ...